Skip to content

Clinical trials

Phase 3 Dyspnea trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyspnea Phase: Phase 3 Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20052
20062
20071
20081
20091
20102
20115
20122
20131
20142
20152
20162
20173
20202
20211
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Withdrawn6
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Assistance Publique - Hôpitaux de Paris3
Amphastar Pharmaceuticals, Inc.2
Flinders University2
Scios, Inc.2
APR Applied Pharma Research s.a.1
American University of Beirut Medical Center1
Baqiyatallah Medical Sciences University1
Bayside Health1
Cambridge University Hospitals NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyspnea36
Pulmonary Disease, Chronic Obstructive13
Asthma7
Heart Failure5
Bronchiolitis2
COVID-192
Acquired Immunodeficiency Syndrome1
Acute Lung Injury1
Cardiomyopathies1
Coma1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.